A comprehensive review and meta-analysis of risk factors for statin-induced myopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comprehensive review and meta-analysis of risk factors for statin-induced myopathy

Published:2018-05-22 Issue:9 Volume:74 Page:1099-1109
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Nguyen Khoa A.,Li Lang,Lu Deshun,Yazdanparast Aida,Wang Lei,Kreutz Rolf P.,Whipple Elizabeth C.,Schleyer Titus K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-018-2482-9/fulltext.html

Reference43 articles.

1. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes the MIRACL study: a randomized controlled trial. JAMA 285:1711–1718

2. Pasternak RC, Smith SC, Bairey-Merz CN et al (2002) ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 40:567–572

3. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22. https://doi.org/10.1016/S0140-6736(02)09327-3

4. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, de Backer G, de Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003. https://doi.org/10.1016/S0195-668X(03)00114-3

5. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D (2008) Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 52:1769–1781. https://doi.org/10.1016/j.jacc.2008.08.039

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients With Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic;Journal of Pharmacology and Pharmacotherapeutics;2024-09-09

2. Allelic frequencies of polymorphism c.521T>C (rs4149056) favor preemptive SLCO1B1 genotyping in Armenia;Drug Metabolism and Personalized Therapy;2024-07-15

3. X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction;Nature Communications;2024-07-02

4. Statins in Chronic Liver Disease: Review of the Literature and Future Role;Seminars in Liver Disease;2024-05

5. A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor;Frontiers in Pharmacology;2024-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3